<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Immunometabolic Gatekeeping: Reconciling Peto's & the T-cell Infiltration Prognostic Paradox - Health AI Hub</title>
    <meta name="description" content="This paper proposes an "immunometabolic gatekeeping" framework, asserting that the inherent metabolic intensity and waste-handling capacity of healthy tissues a">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Immunometabolic Gatekeeping: Reconciling Peto's & the T-cell Infiltration Prognostic Paradox</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.20883v1" target="_blank">2511.20883v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-25
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Naomi Iris van den Berg, Matou≈° Elphick, Kevin Mulder, Omar Bouricha, Omid Sadeghi-Alavijeh, Xiao Fu, Samra Turajlic
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.TO
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.90 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.20883v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.20883v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper proposes an "immunometabolic gatekeeping" framework, asserting that the inherent metabolic intensity and waste-handling capacity of healthy tissues are upstream determinants of anti-tumor immunity and cancer vulnerability. It posits that high-metabolism tissues with poor waste clearance foster immune-exhausting niches even before malignant transformation, thus reconciling several paradoxes in cancer biology.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research provides a novel, integrative lens on cancer vulnerability by emphasizing the host tissue's metabolic environment, moving beyond tumor-centric views. This paradigm shift could lead to more accurate cancer risk assessment and the development of innovative preventative and therapeutic strategies targeting specific tissue metabolisms.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The abstract mentions the use of 'human single-cell expression data' which is a type of high-dimensional data that could potentially be analyzed and interpreted with AI/machine learning models to identify biomarkers for high-risk patients or predict responses to metabolic-immune combination strategies. However, the paper itself does not describe or propose any specific AI application or methodology.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>The core hypothesis is that tissue-intrinsic metabolic intensity and waste-handling capacity act as an upstream gatekeeper for anti-tumor immunity, dictating effective immune function and tissue protection from tumorigenesis.</li>
                    
                    <li>Analysis of human cancers reveals that tumors in high-metabolism tissues (e.g., kidney, brain, eye) often show high T-cell infiltration but are associated with poor prognosis, suggesting pre-existing metabolic environments undermine immune function.</li>
                    
                    <li>Cross-species comparisons support the framework: large mammals with lower mass-specific metabolic rates exhibit lower cancer incidence (Peto's paradox), while long-lived small mammals like bats resist cancer via suppressed glycolysis or altered hypoxia responses leading to lower metabolic byproduct accumulation.</li>
                    
                    <li>The 'immunometabolic gatekeeping' framework suggests that tissues with high metabolic rates and inefficient waste clearance predispose to immune-exhausting microenvironments prior to malignant transformation.</li>
                    
                    <li>This unifying framework provides a coherent explanation for multiple cancer biology paradoxes, including Peto's paradox, the T-cell infiltration non-prognosticity, tissue tropisms, and sex-based inequalities in cancer.</li>
                    
                    <li>The research advocates for a shift in focus from tumor-intrinsic genetic mutations to the host-tissue metabolic environment as a critical determinant of cancer vulnerability and immune failure.</li>
                    
                    <li>The proposed framework offers new principles for identifying high-risk patients and designing novel metabolic-immune combination strategies for cancer prevention and treatment.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study utilized an "integrative synthesis" approach, combining analysis of human single-cell expression data with cross-species comparisons to develop and support its theoretical framework.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The primary finding is the 'immunometabolic gatekeeping' framework, which establishes that high metabolic intensity and poor waste-handling capacity in host tissues create pre-malignant immune-exhausting niches. This mechanism unifies diverse phenomena, explaining the poor prognosis despite high T-cell infiltration in certain human cancers, Peto's paradox, tissue tropisms, and sex-based inequalities.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This work has significant potential clinical impact by enabling the identification of high-risk patients based on their tissue-specific metabolic profiles. It also opens avenues for developing novel metabolic-immune combination strategies, shifting prevention and treatment paradigms to include targeting the host tissue's metabolic environment to enhance anti-tumor immunity.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state limitations; however, as a conceptual framework, its practical application will require extensive validation through experimental and clinical studies.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Future directions include developing tools and biomarkers to identify high-risk patients based on tissue immunometabolic profiles and designing and testing metabolic-immune combination therapies that modulate host tissue metabolism to prevent cancer or enhance anti-tumor responses.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Immunology</span>
                    
                    <span class="tag">Metabolism</span>
                    
                    <span class="tag">Pathology</span>
                    
                    <span class="tag">Preventive Medicine</span>
                    
                    <span class="tag">Precision Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Immunometabolism</span>
                    
                    <span class="tag tag-keyword">Peto's Paradox</span>
                    
                    <span class="tag tag-keyword">T-cell infiltration</span>
                    
                    <span class="tag tag-keyword">Cancer prognosis</span>
                    
                    <span class="tag tag-keyword">Metabolic gatekeeping</span>
                    
                    <span class="tag tag-keyword">Tissue tropism</span>
                    
                    <span class="tag tag-keyword">Cancer prevention</span>
                    
                    <span class="tag tag-keyword">Combination therapy</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Classical models of cancer focus on tumour-intrinsic genetic aberrations and immune dynamics and often overlook how the metabolic environment of healthy tissues shapes tumour development and immune efficacy. Here, we propose that tissue-intrinsic metabolic intensity and waste-handling capacity act as an upstream gatekeeper of anti-tumour immunity, determining whether immune infiltration translates into effective immune function and safeguards the tissue from tumourigenesis. Across human cancers, tumours arising in high-metabolism tissues - like kidney, brain, and eye - tend to show high T cell infiltration but poor prognosis, suggesting pre-existing metabolic environments prior to malignant transformation may undermine immune function. This pattern is mirrored across species: large mammals with lower mass-specific metabolic rates (e.g., elephants, whales) accumulate fewer metabolic byproducts and show lower cancer incidence (Peto's paradox), while long-lived small mammals like bats and naked mole-rats resist tumourigenesis via suppressed glycolysis or altered hypoxia responses leading to lower metabolic rates and/or byproduct accumulation. Through integrative synthesis spanning human single-cell expression data and cross-species comparisons, we outline a framework of 'immunometabolic gatekeeping', where tissues with high metabolic rate and poor waste clearance foster immune-exhausting niches even before transformation. This unifying framework reconciles multiple paradoxes in cancer biology: Peto's paradox, T cell infiltration non-prognosticity, tissue tropisms, and sex-based inequalities, and suggests new principles for identifying high-risk patients and metabolic-immune combination strategies for prevention and treatment. By shifting focus from tumour-intrinsic mutations to host-tissue metabolism, this work offers a novel, integrative lens on cancer vulnerability and immune failure.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>31 pages (including Supplementary materials), 4 main figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>